Cited by 2,542Cancer Genomics and DiagnosticsCancer Cells and MetastasisMicrofluidic and Bio-sensing Technologies

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Allard, W. Jeffrey, Matera, Jeri, Miller, M. Craig, Repollet, Madeline, Connelly, Mark C., Rao, Chandra, Tibbe, Arjan G. J., Uhr, Jonathan W., Terstappen, Leon W. M. M.·2004·Clinical Cancer Research

DOI 10.1158/1078-0432.ccr-04-0378

Published version of a preprint

Open this paper in CoChat — free account

Abstract

PURPOSE: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate the number of circulating tumor cells (CTCs) per 7.5 mL of blood in healthy subjects, patients with nonmalignant diseases, and patients with a variety of metastatic carcinomas. EXPERIMENTAL DESIGN: The CellSearch system was used to enumerate CTCs in 7.5 mL of blood. Blood samples spiked with cells from tumor cell lines were used to establish analytical accuracy, reproducibility, and linearity. Prevalence of CTCs was determined in blood from 199 patients with nonmalignant diseases, 964 patients with metastatic carcinomas, and 145 healthy donors. RESULTS: Enumeration of spiked tumor cells was linear over the range of 5 to 1,142 cells, with an average recovery of >/=85% at each spike level. Only 1 of the 344 (0.3%) healthy and nonmalignant disease subjects had >/=2 CTCs per 7.5 mL of blood. In 2,183 blood samples from 964 metastatic carcinoma patients, CTCs ranged from 0 to 23,618 CTCs per 7.5 mL (mean, 60 +/- 693 CTCs per 7.5 mL), and 36% (781 of 2,183) of the specimens had >/=2 CTCs. Detection of >/=2 CTCs occurred at the following rates: 57% (107 of 188) of prostate cancers, 37% (489 of 1,316) of breast cancers, 37% (20 of 53) of ovarian cancers, 30% (99 of 333) of colorectal cancers, 20% (34 of 168) of lung cancers, and 26% (32 of 125) of other cancers. CONCLUSIONS: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs. CTCs are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-04-0378

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Statistics for Experimenters
Addelman, S., Box, G. E. P., Hunter, W. G., & Hunter, J. S. (1979) · Technometrics · doi:10.2307/1267766 · Cited by 6,753
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Detection and characterization of carcinoma cells in the blood
Racila, E. V., Euhus, D., Weiss, A. J., Rao, C., McConnell, J. D., Terstappen, L. W. M. M., & Uhr, J. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4589 · Cited by 713
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
Ross, A., Cooper, B., Lazarus, H. M., Mackay, W., Moss, T., Ciobanu, N., Tallman, M. S., Kennedy, M., Davidson, N., & Sweet, D. (1993) · Blood · doi:10.1182/blood.v82.9.2605.bloodjournal8292605 · Cited by 487
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., Weber, F., Mertelsmann, R. H., & Kanz, L. (1994) · Blood · doi:10.1182/blood.v83.3.636.636 · Cited by 440
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., et al. (1994) · Blood · doi:10.1182/blood.v83.3.636.bloodjournal833636 · Cited by 357
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues.
Momburg, F., Moldenhauer, G., Hämmerling, G. J., & Möller, P. (1987) · PubMed · Cited by 328
Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., & Uchitomi, Y. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12 · Cited by 309
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
Borgen, E., Naume, B., Nesland, J. M., Kvalheim, G., Beiske, K., Fodstad, Ø., Diel, I., Solomayer, E., Theocharous, P., Coombes, R. C., et al. (1999) · Cytotherapy · doi:10.1080/0032472031000141283 · Cited by 263

Show all 30 references

Research works printed but not linked: 8

Soria JC, Gauthier LR, Raymond E, et al Molecular detection of telomerase positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 1999;5:971-5.
Fehm T, Sagalowsky A, Clifford E, et al Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002;8:2073-84.
Kagan M, Howard D, Bendele T, et al A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 2002;25:104-10.
Rao C, Rutner H, Hermann M, Russell T, Terstappen LWMM. Preservation of blood specimens to prevent breakdown of circulating tumor cells. Proc Am Assoc Cancer Res 2002;43:734
Allard WJ, Hayes DF, Repollet MI, et al A cellular preservative improves the specificity and yield of circulating tumor cells in carcinoma patients[abstract A3482]. Proc Am Soc Clin Oncol 2003;22:866
Motulsky H. The confidence interval of counted variables. Intuitive biostatistics 1995p. 245-9. Oxford University Press New York
Miller MC, Gross S, Allard WJ, et al Circulating tumor cells (CTCs) predict survival in patients with metastatic prostate cancer[abstract A5270]. Proc Am Assoc Cancer Res 2004;45:1215
Cristofanilli M, Reuben JM, Fritsche HA, et al Circulating tumor cells (CTCs): a novel prognostic factor for newly diagnosed metastatic breast cancer (MBC)[abstract A1349]. Proc Am Assoc Cancer Res 2003;44:1349

Sorted by citations

Items 701–800 of 1,004

Circulating Tumor Cells, Enumeration and Beyond
Hou, J., Krebs, M., Ward, T. H., Morris, K. L., Sloane, R. A. S., Blackhall, F. H., & Dive, C. (2010) · Cancers · doi:10.3390/cancers2021236 · Cited by 54
Lateral displacement as a function of particle size using a piecewise curved planar interdigitated electrode array
Han, K.-H., Han, S., & Frazier, A. B. (2009) · Lab on a Chip · doi:10.1039/b909753h · Cited by 54
Imaging cytometry for counting circulating tumor cells: comparative analysis of the CellSearch vs ImageStream systems
López, N., Minguela, A., Villar‐Permuy, F., Ciprian, D., Castillejo, A., Álvarez-López, M.-R., & Soto, J. L. (2013) · Apmis · doi:10.1111/apm.12061 · Cited by 54
Circulating Tumor Cells Are Transcriptionally Similar to the Primary Tumor in a Murine Prostate Model
Helzer, K. T., Barnes, H. E., Day, L., Harvey, J. P., Billings, P. R., & Forsyth, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0801 · Cited by 57
Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma.
Gradilone, A., Iacovelli, R., Cortesi, E., Raimondi, C., Gianni, W., Nicolazzo, C., Petracca, A., Palazzo, A., Longo, F., Frati, L., et al. (2011) · PubMed · Cited by 54
The development of a liquid biopsy for head and neck cancers
Schmidt, H., Kulasinghe, A., Kenny, L., & Punyadeera, C. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.07.014 · Cited by 54
Circulating tumor cells in breast cancer: applications in personalized medicine
Lee, J. S., Magbanua, M. J. M., & Park, J. W. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4014-6 · Cited by 54
Electrochemical biosensor for cancer cell detection based on a surface 3D micro-array
Li, A., Wang, G., Han, Y., Li, T., Jin, P., & Liu, S. (2017) · Lab on a Chip · doi:10.1039/c7lc01117b · Cited by 54
Cellular dielectrophoresis coupled with single-cell analysis
Li, M., & Anand, R. K. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-0896-y · Cited by 54
Characterization of DNA Methylation in Circulating Tumor Cells
Pixberg, C., Schulz, W. A., Stoecklein, N. H., & Neves, R. P. (2015) · Genes · doi:10.3390/genes6041053 · Cited by 53
Interpretation of Changes in Circulating Tumor Cell Counts
Coumans, F. A. W., Ligthart, S. T., & Terstappen, L. W. M. M. (2012) · Translational Oncology · doi:10.1593/tlo.12247 · Cited by 53
Detection and cultivation of circulating tumor cells in gastric cancer
Kološtová, K., Matkowski, R., Gürlich, R., Grabowski, K., Soter, K., Lischke, R., Schützner, J., & Bobek, V. (2015) · Cytotechnology · doi:10.1007/s10616-015-9866-9 · Cited by 53
Biology and significance of circulating and disseminated tumour cells in colorectal cancer
Steinert, G., Schölch, S., Koch, M., & Weitz, J. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-0917-9 · Cited by 53
Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis
Devriese, L. A., Bosma, A. J., Heuvel, M. M. V. D., Heemsbergen, W. D., Voest, E. E., & Schellens, J. H. M. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.07.003 · Cited by 54
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma
Dotan, E., Alpaugh, R. K., Ruth, K. J., Negin, B. P., Denlinger, C. S., Hall, M. J., Astsaturov, I. A., McAleer, C., Fittipaldi, P., Thrash-Bingham, C., et al. (2016) · Pancreas · doi:10.1097/mpa.0000000000000619 · Cited by 53
Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition
Lowes, L. E., & Allan, A. L. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2017.10.004 · Cited by 54
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
Reduzzi, C., Cosimo, S. D., Gerratana, L., Motta, R., Martinetti, A., Vingiani, A., D’Amico, P., Zhang, Y., Vismara, M., Depretto, C., et al. (2021) · Cancers · doi:10.3390/cancers13102356 · Cited by 52
Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review
Hosseinalizadeh, H., Mahmoodpour, M., Bahabadi, Z. R., Hamblin, M. R., & Mirzaei, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113841 · Cited by 52
Circulating tumor cells in breast cancer: clinical validity and utility
Thomas-Bonafos, T., Pierga, J., Bidard, F., Cabel, L., & Kiavué, N. (2024) · npj Breast Cancer · doi:10.1038/s41523-024-00706-7 · Cited by 52
An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer
Liao, M.-Y., Lai, J.-K., Kuo, M. Y., Lu, R., Lin, C., Cheng, P.-C., Liang, K.-H., & Wu, H. (2015) · Oncotarget · doi:10.18632/oncotarget.4453 · Cited by 53
The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy
Guzzo, T. J., McNeil, B. K., Bivalacqua, T. J., Elliott, D. J., Sokoll, L. J., & Schoenberg, M. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.10.008 · Cited by 52
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies
Omlin, A. G., Jones, R. J., van der Noll, R., Satoh, T., Niwakawa, M., Smith, S. A., Graham, J., Ong, M., Finkelman, R. D., Schellens, J. H. M., et al. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0235-5 · Cited by 54
Masked Selection: A Straightforward and Flexible Approach for the Selection of Binders Against Specific Epitopes and Differentially Expressed Proteins by Phage Display
Even-Desrumeaux, K., Névoltris, D., Lavaut, M. N., Alim, K., Borg, J., Audebert, S., Kerfélec, B., Baty, D., & Chames, P. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.025486 · Cited by 55
Detection of circulating tumor cells using targeted surface-enhanced Raman scattering nanoparticles and magnetic enrichment
Shi, W., Paproski, R. J., Moore, R. B., & Zemp, R. J. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.5.056014 · Cited by 52
Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch ® system and the CellCelector ™
Neumann, M. H., Schneck, H., Decker, Y., Schömer, S., Franken, A., Endris, V., Pfarr, N., Weichert, W., Niederacher, D., Fehm, T. N., et al. (2016) · Biotechnology Progress · doi:10.1002/btpr.2294 · Cited by 52
Improving sensitivity and specificity of capturing and detecting targeted cancer cells with anti-biofouling polymer coated magnetic iron oxide nanoparticles
Lin, R., Li, Y., MacDonald, T. J., Wu, H. C., Provenzale, J., Peng, X., Huang, J., Wang, L., Wang, A. Y., Yang, J., et al. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.10.026 · Cited by 52
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
Jaeger, B. A., Neugebauer, J., Andergassen, U., Melcher, C., Schochter, F., Mouarrawy, D., Ziemendorff, G., Clemens, M., von Abel, E., Heinrich, G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173593 · Cited by 52
Exosomes in Pancreatic Cancer: from Early Detection to Treatment
Armstrong, E. A., Beal, E. W., Chakedis, J. M., Paredes, A. Z., Moris, D., Pawlik, T. M., Schmidt, C. R., & Dillhoff, M. E. (2018) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-3693-1 · Cited by 52
Recent advances in microfluidic methods in cancer liquid biopsy
Iliescu, F. S., Poenar, D. P., Yu, F., Ni, M., Chan, K. H., Cima, I., Taylor, H. K., Cima, I., & Iliescu, C. (2019) · Biomicrofluidics · doi:10.1063/1.5087690 · Cited by 51
Genetic profiling of cancer with circulating tumor DNA analysis
Lu, L., Bi, J., & Bao, L. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.11.006 · Cited by 55
A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development
Ruiz-Garcı́a, A., Baverel, P., Bottino, D. C., Dolton, M., Feng, Y., González-García, I., Kim, J., Robey, S., Singh, I., Turner, D. C., et al. (2023) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-023-09850-2 · Cited by 54
Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer
Chen, X., Wang, X., He, H., Liu, Z., Hu, J., & Li, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126276 · Cited by 51
Evaluating tumor metastatic potential by imaging intratumoral acidosis via p H ‐activatable near‐infrared fluorescent probe
Wang, L., Fan, Z., Zhang, J., Changyi, Y., Huang, C., Gu, Y., Xu, Z., Tang, Z., Lu, W., Wei, X., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29153 · Cited by 51
Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial
Hélissey, C., Berger, F., Cottu, P. H., Dieras, V. C., Mignot, L., Servois, V., Bouleuc, C., Asselain, B. J. R., Pelissier, S., Vaucher, I., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.010 · Cited by 51
Continuous labeling of circulating tumor cells with microbeads using a vortex micromixer for highly selective isolation
Lin, M. X., Hyun, K.-A., Moon, H.-S., Sim, T. S., Lee, J., Park, J. C., Lee, S. S., & Jung, H. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.06.016 · Cited by 51
Detection of circulating tumor cells in breast cancer with a refined immunomagnetic nanoparticle enriched assay and nested-RT-PCR
Li, F., Li, Q., Zhou, H.-X., Qi, H., & Deng, C.-Y. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.03.002 · Cited by 51
The Emerging Role of Circulating Tumor Cell Detection in Genitourinary Cancer
Small, A., Gong, Y., Oh, W. K., Hall, S. J., van Rijn, C. J. M., & Galsky, M. D. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.02.2558 · Cited by 51
The added value of circulating tumor cells examination in ovarian cancer staging.
Kološtová, K., Matkowski, R., Jędryka, M., Soter, K., Čegan, M., Pinkas, M., Jakabová, A., Pavlasek, J., Špička, J., & Bobek, V. (2015) · PubMed Central · Cited by 51
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects
Pernot, S., Badoual, C., Terme, M., Castan, F., Cazes, A., Bouché, O., Bennouna, J., François, É., Ghiringhelli, F., de la Fouchardière, C., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.036 · Cited by 51
Cancer Stem Cells and Metastasis
Nandy, S., & Lakshmanaswamy, R. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.07.007 · Cited by 50
Engineering microfluidic chip for circulating tumor cells: From enrichment, release to single cell analysis
Yu, X., Wu, N., Chen, F., Wei, J., & Zhao, Y. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.03.027 · Cited by 50
Hybrid negative enrichment of circulating tumor cells from whole blood in a 3D-printed monolithic device
Chu, C., Liu, R., Ozkaya‐Ahmadov, T., Boya, M., Swain, B. E., Owens, J. M., Burentugs, E., Bilen, M. A., McDonald, J. F., & Sarioglu, A. F. (2019) · Lab on a Chip · doi:10.1039/c9lc00575g · Cited by 53
Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer
Zhang, T., Agarwal, A., Almquist, R. G., Runyambo, D., Park, S., Bronson, E., Boominathan, R., Rao, C., Anand, M., Oyekunle, T. O., et al. (2021) · Biomarker Research · doi:10.1186/s40364-021-00267-y · Cited by 53
Stereotactic Body Radiotherapy for Oligometastasis
Correa, R. J. M., Salama, J. K., Milano, M. T., & Palma, D. A. (2016) · The Cancer Journal · doi:10.1097/ppo.0000000000000202 · Cited by 50
Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour Cells
Mordant, P., Loriot, Y., Lahon, B., Castier, Y., Lesèche, G., Soria, J., Vozenin, M., Decraene, C., & Deutsch, É. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026073 · Cited by 51
Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer
Lim, S. H.-S., Becker, T. M., Chua, W., Ng, W. L., SOUZA, P. D., & Spring, K. J. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202499 · Cited by 50
A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer
Molloy, T. J., Devriese, L. A., Helgason, H. H., Bosma, A. J., Hauptmann, M., Voest, E. E., Schellens, J. H. M., & Veer, L. J. V. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.164 · Cited by 51
Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival
Ligthart, S. T., Coumans, F. A. W., Attard, G., Mulick, A. R., Bono, J. S. D., & Terstappen, L. W. M. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027419 · Cited by 50
Impact of label-free technologies in head and neck cancer circulating tumour cells
Kulasinghe, A., Kenny, L., Perry, C., Thiery, J. P., Jovanovic, L., Vela, I., Nelson, C. C., & Punyadeera, C. (2016) · Oncotarget · doi:10.18632/oncotarget.12086 · Cited by 50
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA
Ye, Z., Wang, C., Wan, S., Mu, Z., Zhang, Z., Abu-Khalaf, M. M., Fellin, F., Silver, D. P., Neupane, M., Jaslow, R. J., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.10.012 · Cited by 50
Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems
Khondakar, K. R., Dey, S., Wuethrich, A., Sina, A. A. I., & Trau, M. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00192 · Cited by 49
Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells
Markov, S. D., Perales-Patón, J., Bockorny, B., Dopazo, A., Muñoz, M., Baños, N., Bonilla, V., Menéndez, C., Durán, Y., Huang, L., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-1166 · Cited by 50
DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution
Zhao, L., Wu, X., Zheng, J., & Dong, D. (2021) · Oncogene · doi:10.1038/s41388-021-01657-0 · Cited by 51
Classification of blood cells and tumor cells using label‐free ultrasound and photoacoustics
Strohm, E. M., & Kolios, M. C. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22698 · Cited by 42
High‐resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
Dent, B., Ogle, L. F., O'Donnell, R. L., Hayes, N., Mallick, U. K., Curtin, N. J., Boddy, A. V., Plummer, E. R., Edmondson, R. J., Reeves, H. L., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29680 · Cited by 49
Construction of carbon nanotube based nanoarchitectures for selective impedimetric detection of cancer cells in whole blood
Liu, Y., Zhu, F., Dan, W., Fu, Y. C., & Liu, S. (2014) · The Analyst · doi:10.1039/c4an00758a · Cited by 49
CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes
Mostert, B., Kraan, J., Sieuwerts, A. M., van der Spoel, P., Vries, J. B., der Smissen, W. J. C. P., Smid, M., Timmermans, A. M., Martens, J. W. M., Gratama, J. W., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.031 · Cited by 50
Dormancy in solid tumors: implications for prostate cancer
Ruppender, N. S., Morrissey, C. M., Lange, P. H., & Vessella, R. L. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9422-z · Cited by 54
Monitoring Serial Changes in Circulating Human Breast Cancer Cells in Murine Xenograft Models
Eliane, J.-P., Repollet, M., Luker, K. E., Brown, M. E., Rae, J. M., Dontu, G., Schott, A. F., Wicha, M. S., Doyle, G. V., Hayes, D. F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0630 · Cited by 49
Realizing the Potential of Plasma Genotyping in an Age of Genotype-Directed Therapies
Luke, J. J., Oxnard, G. R., Paweletz, C. P., Camidge, D. R., Heymach, J. V., Solit, D. B., Johnson, B. E., & for the Cell Free DNA Working Group (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju214 · Cited by 48
Efficient Purification and Release of Circulating Tumor Cells by Synergistic Effect of Biomarker and SiO2@Gel‐Microbead‐Based Size Difference Amplification
Huang, Q., Cai, B., Chen, B., Rao, L., He, Z., He, R., Guo, F., Zhao, L., Kondamareddy, K. K., Liu, W., et al. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500981 · Cited by 49
Circulating Biomarkers in Non–Small-Cell Lung Cancer: Current Status and Future Challenges
Matikas, A., Syrigos, K. N., & Agelaki, S. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.05.021 · Cited by 49
Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients
Ning, Y., Zhang, W., Hanna, D. L., Yang, D., Okazaki, S., Berger, M. D., Miyamoto, Y., Suenaga, M., Schirripa, M., El-Khoueiry, A. B., et al. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.62 · Cited by 49
Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining
Adams, D. L., Alpaugh, R. K., Tsai, S., Tang, C., & Stefansson, S. (2016) · Scientific Reports · doi:10.1038/srep33488 · Cited by 49
Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy
Aggarwal, C., Wang, X., Ranganathan, A., Torigian, D. A., Troxel, A. B., Evans, T. L., Cohen, R. B., Vaidya, B., Rao, C., Connelly, M. C., et al. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.08.008 · Cited by 49
Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders
Foulk, B., Schaffer, M., Gross, S., Rao, C., Smirnov, D. A., Connelly, M. C., Chaturvedi, S., Reddy, M. P., Brittingham, G. P., Mata, M., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.15003 · Cited by 49
How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring
Zeune, L. L., de Wit, S., Berghuis, A. M. S., IJzerman, M. J., Terstappen, L. W. M. M., & Brüne, C. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23576 · Cited by 49
Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
Cieślikowski, W. A., Antczak, A., Nowicki, M. O., Zabel, M., & Budna, J. (2021) · Biomedicines · doi:10.3390/biomedicines9091179 · Cited by 52
Multifunctional carbon nanomaterial hybrids for magnetic manipulation and targeting
Chau, N. D. Q., Ménard‐Moyon, C., Kostarelos, K., & Bianco, A. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.131 · Cited by 49
Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer
Court, C. M., Ankeny, J. S., Sho, S., Hou, S., Li, Q., Hsieh, C., Song, M., Liao, X., Rochefort, M. M., Wainberg, Z. A., et al. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.03.006 · Cited by 48
Detection of Rare Objects by Flow Cytometry: Imaging, Cell Sorting, and Deep Learning Approaches
Voronin, D. V., Kozlova, A. A., Verkhovskii, R. A., Ermakov, A. V., Makarkin, M. A., Inozemtseva, O. A., & Bratashov, D. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072323 · Cited by 48
In Vivo Coinstantaneous Identification of Hepatocellular Carcinoma Circulating Tumor Cells by Dual-Targeting Magnetic-Fluorescent Nanobeads
Xia, W., Li, H., Li, Y., Li, M., Fan, J., Sun, W. C., Li, N., Li, R., Shao, K., & Peng, X. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c04180 · Cited by 50
Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases
Díaz, M., Singh, P., Kotchetkov, I. S., Skakodub, A., Meng, A., Tamer, C., Young, R. J., Reiner, A. S., Panageas, K. S., Ramanathan, L. V., et al. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-03949-1 · Cited by 48
Nondestructive separation/enrichment and rolling circle amplification-powered sensitive SERS enumeration of circulating tumor cells via aptamer recognition
Li, J., Dong, C., Gan, H., Gu, X., Zhang, J., Zhu, Y., Xiong, J., Song, C., & Wang, L. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115273 · Cited by 48
Liquid Biopsy: The Challenges of a Revolutionary Approach in Oncology
Coppola, C. A., Summa, S. D., Matera, G., Pilato, B., Traversa, D., & Tommasi, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115013 · Cited by 52
CellSearch® technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis
Tu, Q., Wu, X., Rhun, É. L., Blonski, M., Wittwer, B., Taillandier, L., Bittencourt, M. D. C., & Faure, G. C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.09.008 · Cited by 52
Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow
Mitchell, M. J., Castellanos, C. A., & King, M. R. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.045 · Cited by 48
Nanobiotechnology for the capture and manipulation of circulating tumor cells
Hughes, A. D., & King, M. R. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.168 · Cited by 48
Expression profiling of circulating tumor cells in metastatic breast cancer
Lang, J. E., Scott, J. H., Wolf, D. M., Novák, P., Punj, V., Magbanua, M. J. M., Zhu, W., Mineyev, N. M., Haqq, C. M., Crothers, J., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3215-0 · Cited by 49
Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue
Lyberopoulou, A., Aravantinos, G., EFSTATHOPOULOS, E. P., Nikiteas, N. I., Bouziotis, P., Isaakidou, A., Papalois, A. E., Marinos, E., & Gazouli, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123902 · Cited by 48
Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis
Tang, L., Zhao, S., Liu, W., Parchim, N. F., Huang, J., Tang, Y., Gan, P., & Zhong, M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-314 · Cited by 49
The Current Role of Circulating Tumor Cells in the Diagnosis and Management of Bone Metastases in Advanced Prostate Cancer
Fred Saad, C., & Pantel, K. (2012) · Future Oncology · doi:10.2217/fon.12.3 · Cited by 48
Isolation and characterization of circulating tumor cells in prostate cancer
Diamond, E., Lee, G. Y., Akhtar, N., Kirby, B. J., Giannakakou, P., Tagawa, S. T., & Nanus, D. M. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00131 · Cited by 48
Prognostic Value of Circulating Tumor Cells According to Immunohistochemically Defined Molecular Subtypes in Advanced Breast Cancer
Munzone, E., Botteri, E., Sandri, M. T., Espósito, A., Adamoli, L., Zorzino, L., Sciandivasci, A., Cassatella, M. C., Rotmensz, N., Aurilio, G., et al. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.07.001 · Cited by 48
Differential Detection of Tumor Cells Using a Combination of Cell Rolling, Multivalent Binding, and Multiple Antibodies
Myung, J. H., Gajjar, K. A., Chen, J., Molokie, R. E., & Hong, S. (2014) · Analytical Chemistry · doi:10.1021/ac501243a · Cited by 47
Combination of Mechanical and Molecular Filtration for Enhanced Enrichment of Circulating Tumor Cells
Meunier, A., Hernández-Castro, J. A., Turner, K., Li, K., Veres, T., & Juncker, D. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b01324 · Cited by 48
Molecular characterization of circulating tumor cells—from bench to bedside
Li, Y., Wu, S., & Bai, F. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.09.013 · Cited by 49
Quantifying HER-2 expression on circulating tumor cells by ACCEPT
Zeune, L. L., van Dalum, G., Decraene, C., Proudhon, C., Fehm, T. N., Neubauer, H. J., Rack, B. K., Alunni‐Fabbroni, M., Terstappen, L. W. M. M., van Gils, S. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186562 · Cited by 48
Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer
Koh, Y., Yagi, S., Akamatsu, H., Kanai, K., Hayata, A., Tokudome, N., Akamatsu, K., Higuchi, M., Kanbara, H., Nakanishi, M., et al. (2019) · Clinical Lung Cancer · doi:10.1016/j.cllc.2019.03.004 · Cited by 47
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells
Reduzzi, C., Vismara, M., Gerratana, L., Silvestri, M., de Braud, F., Raspagliesi, F., Verzoni, E., Cosimo, S. D., Locati, L. D., Cristofanilli, M., et al. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.008 · Cited by 48
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression
Cappelletti, V., Verzoni, E., Ratta, R., Vismara, M., Silvestri, M., Montone, R., Miodini, P., Reduzzi, C., Claps, M., Sepe, P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041475 · Cited by 48
Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors
Menz, A., Bauer, R., Kluth, M., von Bargen, C. M., Gorbokon, N., Viehweger, F., Lennartz, M., Völkl, C., Fraune, C., Uhlig, R., et al. (2021) · Human Pathology · doi:10.1016/j.humpath.2021.05.012 · Cited by 47
Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study
Bark, J. M., Kulasinghe, A., Härtel, G., Leo, P., Warkiani, M. E., Jeffree, R. L., Chua, B., Day, B. W., & Punyadeera, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.681130 · Cited by 47
Breast cancer circulating biomarkers: advantages, drawbacks, and new insights
on behalf of the Solid Tumor Working Party of European Blood and Marrow Transplantation Society (EBMT), Ravelli, A., Reuben, J. M., Lanza, F., Anfossi, S., Cappelletti, M. R., Zanotti, L., Gobbi, A., Senti, C., Brambilla, P., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3944-7 · Cited by 49
Combined Genome and Transcriptome Analysis of Single Disseminated Cancer Cells from Bone Marrow of Prostate Cancer Patients Reveals Unexpected Transcriptomes
Gužvić, M., Braun, B., Ganzer, R., Burger, M., Nerlich, M. N., Winkler, S., Werner‐Klein, M., Czyż, Z. T., Polzer, B. M., & Klein, C. A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0934 · Cited by 47
Circulating Tumor Cells in Prostate Cancer
Hu, B. R., Rochefort, H. M., & Goldkorn, A. (2013) · Cancers · doi:10.3390/cancers5041676 · Cited by 47
Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with Cytokeratin 19-derived CYFRA21-1 and pathological staging
Chen, Q., Ge, F., Cui, W., Wang, F., Yang, Z., Guo, Y., Li, L., Bremner, R. M., & Lin, P. P. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.01.015 · Cited by 47
Establishment and Validation of Circulating Tumor Cell–Based Prognostic Nomograms in First-Line Metastatic Breast Cancer Patients
Giordano, A., Egleston, B. L., Hajage, D., Bland, J., Hortobágyi, G. N., Reuben, J. M., Pierga, J., Cristofanilli, M., & Bidard, F. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3137 · Cited by 47
Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream ® for Detecting (or Monitoring) the Expression of Folate Receptor Alpha
O'Shannessy, D. J., Davis, D. W., Anderes, K. L., & Somers, E. B. (2016) · Biomarker Insights · doi:10.4137/bmi.s35075 · Cited by 47
Circulating Tumour Cell Release after Cement Augmentation of Vertebral Metastases
Mohme, M., Riethdorf, S., Dreimann, M., Werner, S., Maire, C. L., Joosse, S. A., Bludau, F., Müller, V., Neves, R. P., Stoecklein, N. H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07649-z · Cited by 47

Authors: Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M.
Affiliations: 1Immunicon Corporation, Huntingdon Valley, Pennsylvania; and
The University of Texas Southwestern Medical Center (US)
ORCID: Miller, M. Craig
Terstappen, Leon W. M. M.
Venue: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2004-10-15
Volume: 10
Issue: 20
Pages: 6897-6904
ISSN: 1078-0432 (ISSN-L)
1557-3265
DOI: 10.1158/1078-0432.ccr-04-0378
OpenAlex: W2116483002
Cited by: 2,542
References: 30
Citations by year: 2026: 66 · 2025: 81 · 2024: 87 · 2023: 135 · 2022: 117 · 2021: 158 · 2020: 169 · 2019: 166 · 2018: 171 · 2017: 193 · 2016: 197 · 2015: 165 · 2014: 177 · 2013: 161 · 2012: 132
FWCI: 7.52
Type: journal article
Language: en
Open access: closed
Locations: Clinical Cancer Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
Keywords: circulating tumor cells, CellSearch, metastatic carcinoma, prostate cancer, breast cancer, ovarian cancer, colorectal cancer, lung cancer, liquid biopsy
MeSH terms: Adult, Automation, Biological Assay, Carcinoma, Cytological Techniques, Female, Humans, Male, Middle Aged, Neoplastic Cells, Circulating, Neoplasm Metastasis, Sensitivity and Specificity, Reproducibility of Results, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks